KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Accounts Payables (2016 - 2025)

Amgen (AMGN) has 17 years of Accounts Payables data on record, last reported at $2.4 billion in Q4 2025.

  • For Q4 2025, Accounts Payables rose 24.06% year-over-year to $2.4 billion; the TTM value through Dec 2025 reached $2.4 billion, up 24.06%, while the annual FY2025 figure was $2.4 billion, 24.06% up from the prior year.
  • Accounts Payables reached $2.4 billion in Q4 2025 per AMGN's latest filing, down from $2.8 billion in the prior quarter.
  • Across five years, Accounts Payables topped out at $3.0 billion in Q2 2025 and bottomed at $1.2 billion in Q3 2021.
  • Average Accounts Payables over 5 years is $1.7 billion, with a median of $1.5 billion recorded in 2022.
  • Peak YoY movement for Accounts Payables: fell 5.92% in 2023, then skyrocketed 87.05% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $1.4 billion in 2021, then rose by 15.08% to $1.6 billion in 2022, then increased by 1.15% to $1.6 billion in 2023, then grew by 20.0% to $1.9 billion in 2024, then rose by 24.06% to $2.4 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Accounts Payables were $2.4 billion in Q4 2025, $2.8 billion in Q3 2025, and $3.0 billion in Q2 2025.